CHIEF MEDICAL OFFICER · Enliven Therapeutics, Inc. · Common Stock
Side
M
Value
$99K
Shares
40.0K
Price
$2.48
Executed
Mar 25, 2026
Disclosed
Mar 27, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 25 executedMar 27, 2026 disclosed
ELVN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+16 / 25
$99K reported value · 160.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Collins Helen Louise filed this Form 4 reporting a option exercise of ELVN on Mar 25, 2026. It became public on Mar 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF MEDICAL OFFICER
Collins Helen Louisecik:0001701247
Issuer
Enliven Therapeutics, Inc.cik:0001672619
Revision history · 0
No field has changed since this record was first ingested.
